Sort
11,323 grants matching “glioblastoma”
The mechanisms driving brain oncogenesis by FGFR-TACC gene fusions
$366,858Antonio Iavarone · Columbia University Health Sciences · R01 · FY2017 · CA
The mechanisms driving brain oncogenesis by FGFR-TACC gene fusions
$366,858Antonio Iavarone · Columbia University Health Sciences · R01 · FY2016 · CA
The mechanisms driving brain oncogenesis by FGFR-TACC gene fusions
$366,858Antonio Iavarone · Columbia University Health Sciences · R01 · FY2018 · CA
Mitigation of preanalytic factors influencing brain tumor protein phosphorylation
$366,857Joanna Phillips · University Of California, San Francisco · U01 · FY2019 · CA
Inherited genetic variation and penetrance of Hereditary Paraganglioma-Pheochromocytoma Syndrome
$366,745Lauren Fishbein · University Of Colorado Denver · R01 · FY2020 · CA
Project 4: Targeting 4EBP1 in glioblastoma
$366,730William A Weiss · University Of California, San Francisco · P50 · FY2018 · CA
Project 2: Monitoring metabolism in GBM using hyperpolarized C-13 imaging and H-1 MRSI
$366,649Sarah J. Nelson · University Of California, San Francisco · P50 · FY2018 · CA
Tumor Microenvironment in Modulating the Primary & Metastatic Brain Tumors
$366,584Johanna Joyce · Sloan-Kettering Inst Can Research · U54 · FY2007 · CA
Molecular basis for the impact of sex on brain tumorigenesis
$366,581Joshua B Rubin · Washington University · R01 · FY2023 · CA
Damaged RNA as a mediator of alkylation responses
$366,581Nima Mosammaparast · Washington University · R01 · FY2023 · CA
Damaged RNA as a mediator of alkylation responses
$366,581Nima Mosammaparast · Washington University · R01 · FY2022 · CA
Molecular basis for the impact of sex on brain tumorigenesis
$366,581Joshua B Rubin · Washington University · R01 · FY2022 · CA
Project 1: Modeling tumor evolution in mouse and organoid models
$366,414Raul Rabadan · Columbia University Health Sciences · U54 · FY2015 · CA
Targeting Glioblastoma with a Nuclear-penetrating Anti-DNA Autoantibody
$366,406James E. Hansen · Yale University · R01 · FY2023 · NS
Targeting Glioblastoma with a Nuclear-penetrating Anti-DNA Autoantibody
$366,406James E. Hansen · Yale University · R01 · FY2022 · NS
Targeting Glioblastoma with a Nuclear-penetrating Anti-DNA Autoantibody
$366,406James E. Hansen · Yale University · R01 · FY2020 · NS
Targeting Glioblastoma with a Nuclear-penetrating Anti-DNA Autoantibody
$366,406James E. Hansen · Yale University · R01 · FY2021 · NS
Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms
$366,394Steven L Carroll · Medical University Of South Carolina · R01 · FY2024 · NS
Project 3: MRI Imaging of Redox Active Fe Predicts GBM Responses to Pharmacological Ascorbate
$366,357Bryan Allen · University Of Iowa · P01 · FY2022 · CA
Glioblastoma stem cells therapy
$366,301Bakhos A. Tannous · Massachusetts General Hospital · R01 · FY2009 · NS
The Role of IDH1 Mutations in Gliomagenesis and Metabolism
$366,296Hai Yan · Duke University · R01 · FY2019 · CA
The role of ICOSL in renal protection
$366,287Eunsil Hahm · Rush University Medical Center · R01 · FY2021 · DK
Metabolic interactions between tumor cells and the immune system in GBM: A potential Achilles heel of GBM for novel therapeutics
$366,265Loic Pierre Deleyrolle · Mayo Clinic Jacksonville · R01 · FY2025 · NS
Regulation of Glioma Cell Migration by RasGRP3
$366,250Chaya Brodie · Henry Ford Health System · R01 · FY2010 · NS
Regulation of Glioma Cell Migration by RasGRP3
$366,250Chaya Brodie · Henry Ford Health System · R01 · FY2009 · NS